Related Experiment Video
Updated: May 6, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Linear Growth During Treatment With a Simplified, Combined Protocol: Secondary Analyses of Severely Wasted Children
Grace Heymsfield1, Kevin Stephenson2, Zachary Tausanovitch1
1International Rescue Committee, New York City, New York, USA.
Insights
A simplified treatment protocol for acute malnutrition in children using reduced ready-to-use therapeutic food (RUTF) doses showed similar linear growth outcomes compared to standard treatments. This simplified approach effectively manages moderate acute malnutrition (MAM) and severe acute malnutrition (SAM) without compromising child development.
Area of Science:
- Pediatrics
- Global Health
- Nutrition Science
Background:
- Acute malnutrition, including moderate acute malnutrition (MAM) and severe acute malnutrition (SAM), affects millions of children globally.
- Standard treatment protocols often involve weight-based dosing of ready-to-use therapeutic food (RUTF), which can be resource-intensive.
- A simplified, combined protocol using fixed daily RUTF sachets for MAM and SAM has shown comparable recovery rates to standard treatments.
Purpose of the Study:
- To conduct a secondary analysis of a cluster-randomized controlled trial to compare linear growth in children with severe acute malnutrition (SAM) treated with a simplified versus a standard RUTF dosing protocol.
- To evaluate the impact of reduced RUTF dosage on linear and ponderal growth velocity in children admitted with mid-upper arm circumference (MUAC) < 115 mm.
Main Methods:
- Secondary analysis of data from a cluster-based randomized controlled trial in Kenya and South Sudan.
- Comparison of linear growth (height-for-age z-score change) and ponderal growth (MUAC and weight gain velocity) between children receiving a simplified RUTF protocol and those receiving standard treatment.
- Growth curves were visualized, and statistical analyses were performed to compare growth velocities between treatment arms.
Main Results:
- Adjusted height-for-age z-score (HAZ) change was negative but similar across both the standard and simplified treatment arms (difference: 0.03; 95% CI: -0.12, 0.18).
- Unadjusted linear growth velocity was comparable between the standard (1.8 ± 0.7 mm/week) and simplified (1.7 ± 0.7 mm/week) arms, with adjusted analysis showing similar results.
- No significant differences were observed in MUAC and weight gain velocities between the treatment groups.
Conclusions:
- Reducing the RUTF dose for children with severe acute malnutrition (SAM) within a simplified treatment protocol does not negatively impact linear growth or other growth velocities during treatment.
- The simplified, combined protocol offers a viable alternative for managing acute malnutrition, potentially simplifying logistics and resource allocation without compromising growth outcomes.
Abstract:
A simplified, combined protocol treats children with moderate acute malnutrition (MAM), defined by mid-upper arm circumference (MUAC) of < 125 and ≥ 115 mm and no oedema, with 1 daily sachet of ready-to-use therapeutic food (RUTF) and those with severe acute malnutrition (SAM), defined by MUAC < 115 mm and/or oedema, with two daily sachets of RUTF. This protocol was previously shown to result in non-inferior recovery compared to standard treatment that used higher, weight-based RUTF dosing among children with SAM and ready-to-use supplementary food (RUSF) for MAM in a cluster-based randomised controlled trial in Kenya and South Sudan. We conducted a secondary analysis of this trial to compare linear growth among children admitted with MUAC < 115 mm. Linear and ponderal growth were calculated from admission to discharge and visualised using aggregate growth curves. HAZ change adjusted for admission characteristics was negative across the course of treatment but similar across arms [-0.21 ± 0.18 SE in the standard arm, -0.24 ± 0.18 SE in simplified; difference (95% confidence interval) 0.03 (-0.12, 0.18)]. The unadjusted mean ± SE linear growth velocity from admission to discharge was 1.8 ± 0.7 mm/week in the standard arm compared to 1.7 ± 0.7 mm/week in the simplified arm [difference = 0.09 (-0.36, 0.53)] and similar in adjusted analysis. MUAC and weight gain velocities were not significantly different by treatment arm. Reducing the RUTF dose prescribed to children during SAM treatment does not appear to affect linear growth or other growth velocities during treatment.
More Related Videos
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
07:20Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
Published on: August 9, 2024
Related Concept Videos
Dosage Regimens: Designs and Approaches
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion